Literature DB >> 8692421

Atypical MRI findings in treatment-related leukoencephalopathy: case report.

Y Ohmoto1, K Kajiwara, S Kato, T Nisizaki, H Ito, S Tamura.   

Abstract

A patient with acute myeloblastic leukaemia showed atypical findings on MRI following combination therapy including intrathecal methotrexate and radiation. MRI findings not previously been reported are ring as well as patchy enhancement, marked mass effect and lesions extending to the putamen and corpus callosum.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8692421     DOI： 10.1007/bf00604796

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  30 in total

1.  Primary intracranial lymphoma. An important differential diagnosis in magnetic resonance imaging of the brain.

Authors:  C S McKinstry; B S Worthington; P D Lewis; J Lowe
Journal:  Acta Radiol Suppl       Date:  1986

2.  Paraparesis following intrathecal cytosine arabinoside: a case report with neuropathologic findings.

Authors:  A C Breuer; S W Pitman; D M Dawson; W C Schoene
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

3.  Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.

Authors:  H Norrell; C B Wilson; D E Slagel; D B Clark
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

4.  Current status of intrathecal chemotherapy for human meningeal neoplasms.

Authors:  W A Bleyer
Journal:  Natl Cancer Inst Monogr       Date:  1977-12

5.  MR findings in methotrexate-induced CNS abnormalities.

Authors:  F Ebner; G Ranner; I Slavc; C Urban; R Kleinert; H Radner; R Einspieler; E Justich
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

6.  Early diagnosis of leukoencephalopathy of acute lymphocytic leukemia by MRI.

Authors:  M Ito; Y Akiyama; R Asato; M Kubota; Y Kasai; E Rios; H Mikawa
Journal:  Pediatr Neurol       Date:  1991 Nov-Dec       Impact factor: 3.372

7.  Focal pontine leukoencephalopathy in immunosuppressed patients.

Authors:  H V Vinters; K H Anders; P Barach
Journal:  Arch Pathol Lab Med       Date:  1987-02       Impact factor: 5.534

Review 8.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

9.  Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.

Authors:  N J Winick; S D Smith; J Shuster; S Lauer; M D Wharam; V Land; G Buchanan; G Rivera
Journal:  J Clin Oncol       Date:  1993-02       Impact factor: 44.544

10.  A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission.

Authors:  F L Johnson; E D Thomas; B S Clark; R L Chard; J R Hartmann; R Storb
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245
View more
  4 in total

1.  Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.

Authors:  Ji Yeon Kim; Sung Tae Kim; Do-Hyun Nam; Jung-Il Lee; Kwan Park; Doo-Sik Kong
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

2.  Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.

Authors:  Ajaya R Pande; Kumiko Ando; Reiichi Ishikura; Yuki Nagami; Masayo Ogawa; Norihiko Kamikonya; Yumi Kaneda; Takakuni Tanizawa; Norio Nakao
Journal:  Radiat Med       Date:  2006-08

3.  MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy.

Authors:  M Oka; S Terae; R Kobayashi; Y Sawamura; K Kudoh; K K Tha; M Yoshida; M Kaneda; Y Suzuki; K Miyasaka
Journal:  Neuroradiology       Date:  2003-05-22       Impact factor: 2.804

4.  Methotrexate induced leucoencephalopathy: A stroke mimic.

Authors:  Tushar D Gosavi; Mohammed Tauqeer Ahmad; Lai-Heng Lee; Shih-Hui Lim
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.